These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 26850786

  • 1. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
    Bircsak KM, Gupta V, Yuen PY, Gorczyca L, Weinberger BI, Vetrano AM, Aleksunes LM.
    J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
    Pollex EK, Anger G, Hutson J, Koren G, Piquette-Miller M.
    Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988
    [Abstract] [Full Text] [Related]

  • 3. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
    Ceckova M, Libra A, Pavek P, Nachtigal P, Brabec M, Fuchs R, Staud F.
    Clin Exp Pharmacol Physiol; 2006 May; 33(1-2):58-65. PubMed ID: 16445700
    [Abstract] [Full Text] [Related]

  • 4. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
    Pollex E, Lubetsky A, Koren G.
    Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
    [Abstract] [Full Text] [Related]

  • 5. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta.
    Gedeon C, Anger G, Piquette-Miller M, Koren G.
    Placenta; 2008 Jan; 29(1):39-43. PubMed ID: 17923155
    [Abstract] [Full Text] [Related]

  • 6. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.
    Gedeon C, Behravan J, Koren G, Piquette-Miller M.
    Placenta; 2006 Jan; 27(11-12):1096-102. PubMed ID: 16460798
    [Abstract] [Full Text] [Related]

  • 7. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
    Feinshtein V, Erez O, Ben-Zvi Z, Eshkoli T, Sheizaf B, Sheiner E, Holcberg G.
    Am J Obstet Gynecol; 2013 Dec; 209(6):573.e1-573.e15. PubMed ID: 23933222
    [Abstract] [Full Text] [Related]

  • 8. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
    Imai Y, Tsukahara S, Asada S, Sugimoto Y.
    Cancer Res; 2004 Jun 15; 64(12):4346-52. PubMed ID: 15205350
    [Abstract] [Full Text] [Related]

  • 9. Effect of oxygen on multidrug resistance in term human placenta.
    Javam M, Audette MC, Iqbal M, Bloise E, Gibb W, Matthews SG.
    Placenta; 2014 May 15; 35(5):324-30. PubMed ID: 24685282
    [Abstract] [Full Text] [Related]

  • 10. Effect of oxygen on multidrug resistance in the first trimester human placenta.
    Lye P, Bloise E, Dunk C, Javam M, Gibb W, Lye SJ, Matthews SG.
    Placenta; 2013 Sep 15; 34(9):817-23. PubMed ID: 23790363
    [Abstract] [Full Text] [Related]

  • 11. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction.
    Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS, Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B, Keelan JA.
    FASEB J; 2007 Nov 15; 21(13):3592-605. PubMed ID: 17595345
    [Abstract] [Full Text] [Related]

  • 12. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
    Ikeda K, Yamasaki K, Homemoto M, Yamaue S, Ogawa M, Nakao E, Fukunaga Y, Nakanishi T, Utoguchi N, Myotoku M, Hirotani Y.
    Pharmazie; 2012 Jan 15; 67(1):86-90. PubMed ID: 22393837
    [Abstract] [Full Text] [Related]

  • 13. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity.
    Szilagyi JT, Vetrano AM, Laskin JD, Aleksunes LM.
    Placenta; 2017 Jul 15; 55():29-36. PubMed ID: 28623970
    [Abstract] [Full Text] [Related]

  • 14. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
    Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, Mao Q.
    Am J Physiol Endocrinol Metab; 2006 May 15; 290(5):E798-807. PubMed ID: 16352672
    [Abstract] [Full Text] [Related]

  • 15. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
    Szilagyi JT, Composto-Wahler GM, Joseph LB, Wang B, Rosen T, Laskin JD, Aleksunes LM.
    Pharmacol Res; 2019 Mar 15; 141():331-342. PubMed ID: 30610963
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.
    Francois LN, Gorczyca L, Du J, Bircsak KM, Yen E, Wen X, Tu MJ, Yu AM, Illsley NP, Zamudio S, Aleksunes LM.
    Placenta; 2017 Mar 15; 51():57-63. PubMed ID: 28292469
    [Abstract] [Full Text] [Related]

  • 17. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
    Ripperger A, Benndorf RA.
    Biochem Pharmacol; 2016 Mar 15; 104():139-47. PubMed ID: 26903388
    [Abstract] [Full Text] [Related]

  • 18. The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis.
    Blazquez AG, Briz O, Gonzalez-Sanchez E, Perez MJ, Ghanem CI, Marin JJ.
    Toxicol Appl Pharmacol; 2014 May 15; 277(1):77-85. PubMed ID: 24631341
    [Abstract] [Full Text] [Related]

  • 19. Antiepileptic drugs alter the expression of placental carriers: An in vitro study in a human placental cell line.
    Rubinchik-Stern M, Shmuel M, Eyal S.
    Epilepsia; 2015 Jul 15; 56(7):1023-32. PubMed ID: 26032972
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).
    Meyer zu Schwabedissen HE, Grube M, Dreisbach A, Jedlitschky G, Meissner K, Linnemann K, Fusch C, Ritter CA, Völker U, Kroemer HK.
    Drug Metab Dispos; 2006 Apr 15; 34(4):524-33. PubMed ID: 16415123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.